Physiological antagonism of angiotensin II and lipopolysaccharides in early endotoxemia: Pharmacometric analysis

Polish Journal of Pharmacology

Volumn 55, Issue 5, 2003, Pages 753-762

  Grześk, Grzegorz ^a   Szadujkis Szadurski, Leszek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Angiotensin II; Lipopolysaccharides; Nitric oxide; Rat tail artery; Receptor reserve; Septicemia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; ARGIPRESSIN; BACTERIUM LIPOPOLYSACCHARIDE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOCRINE FUNCTION; ENDOTOXEMIA; NONHUMAN; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING; RECEPTOR OCCUPANCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE;

ANGIOTENSIN II; ANIMALS; ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENDOTOXEMIA; LIPOPOLYSACCHARIDES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NOREPINEPHRINE; PERFUSION; PHENYLEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION; TAIL; TIME FACTORS;

EID: 0348218173     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. 2-adrenoceptor sensitivity during endotoxemia. Amer. J. Physiol., 1994, 267, H2171-H2178.
2. Boke T., Malik K.U.: Enhancement by locally generated angiotensin II of release of the adrenergic transmitter in the isolated rat kidney. J. Pharmacol. Exp. Ther., 1983, 226, 900-907.
3. Bucher M., Hobbhahn J., Kurtz A.: Nitric oxide-dependent down-regulation of angiotensin II type 2 receptor during experimental sepsis. Crit. Care Med., 2001, 29, 1750-1755.
4. Burnier M., Centeno G., Waeber G., Centeno C., Burki E.: Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells. Brit. J. Pharmacol., 1995, 116, 2624-2630.
5. Chłopicki S., Bartus J.B., Gryglewski R.J.: Biphasic response to lipopolysaccharides from E. coli in the isolated ventilated blood-perfused rat lung. J. Physiol. Pharmacol., 1999, 50, 551-565.
6. 2-adrenoceptors: evidence for and against a further subdivision. Pharmacol. Ther., 1989, 44, 241-284.
7. Duckles S.P.: Angiotensin II potentiates responses of the rabbit basilar artery to adrenergic nerve stimulation. Life Sci., 1981, 28, 635-640.
8. Faber J.E.: In situ analysis of α-adrenoceptors on arteriolar and venular smooth muscle in rat sceletal muscle microcirculation. Circ. Res., 1988, 62, 37-50.
9. Gryglewski R., Chłopicki S., Uracz W., Marcinkiewicz E.: Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med. Sci. Mon., 2001, 7, 1-16.
10. Gryglewski R., Wolkow P.P., Uracz W.: Protective role of pulmonary nitric oxide in the acute phase of endotoxemia in rats. Circ. Res., 1998, 82, 819-827.
11. 1-adrenoceptor function in pretreated with lipopolysaccharides rat tail artery. Pol. J. Pharmacol., 2001, 53, 605-613.
12. G-nitro-L-arginine methyl ester and vasopressin in endotoxin-treated pithed rats. Eur. J. Pharmacol., 1992, 224, 63-69.
13. Hock C.A., Yin K., Yue G., Wong P.Y.K.: Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Amer. J. Physiol., 1997, 272, H843-H850.
14. Kazmierski W.M., Woberg G., Wilson J.G., Smith S.R., Williams D.S., Throp H.H., Molina L.: Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock. Proc. Nat. Acad. Sci. USA, 1996, 93, 9138-9141.
15. Kenakin T.: Pharmacologic Analysis of Drug-Receptor Interaction. 3rd edn., Raven Press, New York, 1997.
16. Kilbourn R.G., Belloni P.: Endothelial cell production of nitrogen oxides in response to interferon γ in combination with tumor necrosis factor, interleukin-1 and endotoxin. J. Nat. Cancer Inst., 1990, 82, 772-776.
17. Koyama S.: Participation of central α-receptors in hemodynamic response to E. coli endotoxin. Amer. J. Physiol., 1984, 247, R655-R662.
18. MacLean M.R., Ungar A.: Effects of the renin-angiotensin system on the reflex response of the adreneal medulla to hypotension in the dog. J. Physiol., 1986, 373, 343-352.
19. MacMicking J.D., Nathan C., Hom G., Hartrain N., Flether D.S., Traumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N., Chen H., Mudgett J.S.: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell, 1995, 81, 641-650.
20. Medgett I.C., Rajanayagam M.A.S.: Effects of reduced calcium ion concentration and of diltiazem on vasoconstrictor responses to noradrenaline and sympathetic nerve stimulation in rat isolated tail artery. Brit. J. Pharmacol., 1984, 83, 889-898.
21. Morinelli T.A., Webb J.G., Faffa A.A., Privitera P.J., Margolius H.S.: A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats. J. Pharmacol. Exp. Ther., 2001, 296, 71-76.
22. Nicholas T.E.: A perfused tail artery preparation from the rat. J. Pharm. Pharmacol. 1969, 21, 826-832.
23. 2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation. Circ. Res., 1991, 68, 232-244.
24. Olsson L.E., Wheeler M.A., Sessa W.C., Wiess R.M.: Bladder instillation and intraperitoneal injection of Eschericha coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder. J. Pharmacol. Exp. Ther., 1998, 284, 1203-1208.
25. Patten M., Bünemann J., Thoma B., Krämer E., Thoenses M., Stübe S., Mittmann C., Wieland T.: Endotoxin induces desensitization of cardiac endothelin-1 receptor signaling by increased expression of RGS-4 and RGS-16. Cardiovasc. Res., 2002, 53, 156-164.
26. Prudy R.E., Weber M.A.: Angiotensin II amplification of α-adrenergic vasoconstriction: role of receptor reserve. Circ. Res., 1988, 63, 748-757.
27. αi. J. Pharmacol. Exp. Ther., 1997, 283, 925-931.
28. Szabo C., Mitchell J.A., Thiemermann C., Vane JR.: Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxic shock. Brit. J. Pharmacol., 1993, 108, 786-789.
29. Van Rossum J.: Cumulative dose-response curves. Technique for the making of dose-responses curves in isolated organs and the evaluation of drugs parameters. Arch. Int. Pharmacodyn. Thér., 1963, 143, 299-330.
30. Vane JR., Gryglewski R.J., Botting R.M.: The endothelial cells as a metabolic and endocrine organ. Trends Pharmacol. Sci., 1987, 8, 491-496.
31. Vanhoutte P.M., Verbeuren T.J., Webb R.C.: Local modulation of adrenergic neuroeffector interaction in the blood vessel wall. Physiol. Rev., 1981, 61, 151-247.
32. Weber M.A., Drayer J.I., Purdy R.E., Frankfurt P.P., Ricci B.A.: Enhancement of the pressor response to norepinephrine by angiotensin in the conscious rabbit. Life Sci., 1985, 36, 1897-1907.
33. Wheeler D.D., Bernard G.R.: Treating patients with severe sepsis. N. Engl. J. Med., 1999, 340, 207-214.
34. Zeigler D.W., Johnson J.A., Koivunen D.G., Siripaisarnpipat S., Fowler W.L. Jr., Dostal D.E., Payne C.G.: Angiotensin receptors and pressor hyperresponsiveness in renal prehypertensive rabbits. Amer. J. Physiol., 1986, 251, H196-H204.